Search

Your search keyword '"Hochman, Judith S"' showing total 1,733 results

Search Constraints

Start Over You searched for: Author "Hochman, Judith S" Remove constraint Author: "Hochman, Judith S"
1,733 results on '"Hochman, Judith S"'

Search Results

3. International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial

4. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

5. Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

6. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

7. Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study

9. Mentoring Underrepresented Minority Physician-Scientists to Success

10. Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD

12. Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life

13. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19

16. CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial

18. Go Red for Women Strategically Focused Research Network: Summary of Findings and Network Outcomes

20. Impact of Complete Revascularization in the ISCHEMIA Trial

21. Myocardial Infarction in the ISCHEMIA Trial

22. From Stigma to Validation: A Qualitative Assessment of a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities

23. Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations JACC State-of-the-Art Review

24. Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial

25. Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial

27. Abstract 14153: P2Y12 Inhibitors and Quality of Life Outcomes in Critically Ill Patients Hospitalized for COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a Randomized Clinical Trial

28. Abstract 13200: Changes in Thrombi-Inflammatory Biomarkers Associated With Therapeutic Heparin in Non-Critically Ill Patients Hospitalized With COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a and ATTACC Randomized Clinical Trial

29. Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial

30. Cardiometabolic Comorbidity Burden and Circulating Biomarkers in Patients with Chronic Coronary Disease in the ISCHEMIA Trials

31. ISCHEMIA-EXTEND studies: Rationale and design

32. The Most Valuable Resource Is Time: Insights From a Novel National Program to Improve Retention of Physician-Scientists With Caregiving Responsibilities.

34. Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial

36. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

37. Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial

38. Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia

39. Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

40. The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction Insights From the ACTION Registry

41. An Innovative Program to Support Gender Equity and Success in Academic Medicine: Early Experiences From the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists.

42. Comparative Prognostic Utility of Coronary CT and Invasive Angiography

43. Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial

45. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

46. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease : Insights From the ISCHEMIA Trial

47. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19

48. Abstract 14850: Effect of Therapeutic-Dose Heparin on Acute Kidney Injury in Non-Critically Ill Hospitalized Patients With Covid-19: The Activ4a and Attac Randomized Trial

Catalog

Books, media, physical & digital resources